Sector ratings Johnson & Johnson

Equities

Market Closed - Nyse Other stock markets 21:00:02 06/03/2026 GMT			5-day change	1st Jan Change
240.40 ^USD	+0.32%		-3.23%	+16.16%

03-06	Johnson & Johnson Units to Pay $65 Million to Settle Tracleer Antitrust Lawsuit	MT
03-06	Halozyme Therapeutics Says Johnson & Johnson Wins FDA Approval for Blood Cancer Treatment	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI
JOHNSON & JOHNSON	579B	BBB
ELI LILLY AND COMPANY	885B	A
ABBVIE INC.	407B	AA
ROCHE HOLDING AG	350B	AA
NOVARTIS AG	302B	AAA
ASTRAZENECA PLC	301B	A
MERCK & CO., INC.	286B	A
AMGEN INC.	199B	A
GILEAD SCIENCES, INC.	179B	AAA
NOVO NORDISK A/S	171B	A
PFIZER INC.	154B	BBB
BRISTOL-MYERS SQUIBB COMPANY	123B	A
VERTEX PHARMACEUTICALS INCORPORATED	116B	AA
GSK PLC	109B	AA
SANOFI	107B	A
CHUGAI PHARMACEUTICAL CO., LTD.	100B	AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	57B	AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	53.42B	AA
HALEON PLC	44.97B	AA
ALNYLAM PHARMACEUTICALS, INC.	42.53B	AA
Average	228.34B	AA
Weighted average by Cap.		AA